摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯-1-(3-甲基-2-噻吩基)-1-丁酮 | 157925-24-1

中文名称
4-氯-1-(3-甲基-2-噻吩基)-1-丁酮
中文别名
——
英文名称
4-chloro-β-methyl-butyrothienone
英文别名
4-Chloro-1-(3-methylthiophen-2-yl)butan-1-one
4-氯-1-(3-甲基-2-噻吩基)-1-丁酮化学式
CAS
157925-24-1
化学式
C9H11ClOS
mdl
——
分子量
202.705
InChiKey
BHDFZLRXPWTDAJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    326.8±32.0 °C(Predicted)
  • 密度:
    1.184±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    45.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    4-氯-1-(3-甲基-2-噻吩基)-1-丁酮盐酸sodium hydroxidepotassium carbonate 作用下, 以 二丁醚异丙醇 为溶剂, 反应 8.0h, 生成
    参考文献:
    名称:
    The synthesis of novel GABA uptake inhibitors. Part 2. Synthesis of 5-hydroxytiagabine, a human metabolite of the GABA reuptake inhibitor tiagabine
    摘要:
    (R)-1-(4-(2,5-Dihydro-3-methyl-5-oxothien-2-ylidene)-4-(3-methyl-2-thienyl)butyl)-3- piperidinecarboxylic acid (5-hydroxytiagabine) 13, has been prepared in 8 steps from 2-bromo-3-methylthiophene 3. Key steps are Grignard reactions, displacement of heteroaromatic chlorine with methoxy, and simultaneously demethylation and opening of a hydroxymethylcyclopropane with bromotrimethylsilane. An alternative approach involving acylation of 2-lithio-3-methylthiophene 17a was found less satisfying. A metalloporphyrin assisted hydroxylation of tiagabine 1 also yielded the target metabolite. The structure of 5-hydroxytiagabine was confirmed by NMR-data including COSY, ROESY, HMQC and HMBC experiments.
    DOI:
    10.1016/s0040-4020(01)85345-x
  • 作为产物:
    描述:
    2-溴-3-甲基噻吩oxoniummagnesium 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 生成 4-氯-1-(3-甲基-2-噻吩基)-1-丁酮
    参考文献:
    名称:
    The synthesis of novel GABA uptake inhibitors. Part 2. Synthesis of 5-hydroxytiagabine, a human metabolite of the GABA reuptake inhibitor tiagabine
    摘要:
    (R)-1-(4-(2,5-Dihydro-3-methyl-5-oxothien-2-ylidene)-4-(3-methyl-2-thienyl)butyl)-3- piperidinecarboxylic acid (5-hydroxytiagabine) 13, has been prepared in 8 steps from 2-bromo-3-methylthiophene 3. Key steps are Grignard reactions, displacement of heteroaromatic chlorine with methoxy, and simultaneously demethylation and opening of a hydroxymethylcyclopropane with bromotrimethylsilane. An alternative approach involving acylation of 2-lithio-3-methylthiophene 17a was found less satisfying. A metalloporphyrin assisted hydroxylation of tiagabine 1 also yielded the target metabolite. The structure of 5-hydroxytiagabine was confirmed by NMR-data including COSY, ROESY, HMQC and HMBC experiments.
    DOI:
    10.1016/s0040-4020(01)85345-x
点击查看最新优质反应信息

文献信息

  • Synthesis and biological studies of some novel antiinflammatory aryl-hydroxy-amino-ketones
    作者:D Hadjipavlou-Litina、E Rekka、L Hadjipetrou-Kourounakis、P Kourounakis
    DOI:10.1016/0223-5234(91)90216-a
    日期:1991.1
    The synthesis of some 4-hydroxy-(or amino)-ethyl-amino butyrophenones or butyrothienones is described. The interconversion of these compounds to the corresponding 5-aryl-4-oxa-1-azabicyclo[3,3,0]octanes is presented. The title compounds demonstrated good antiinflammatory activity in the adjuvant induced disease model. They also possessed antinociceptive, immuno-modulating and antioxidant activity, properties which are probably involved in the mechanism of their action.
  • HADJIPAVLOU-LITINA, D.;REKKA, E.;HADJIPETROU-KOUROUNAKIS, L.;KOUROUNAKIS,+, EUR. J. MED. CHEM., 26,(1991) N, C. 85-90
    作者:HADJIPAVLOU-LITINA, D.、REKKA, E.、HADJIPETROU-KOUROUNAKIS, L.、KOUROUNAKIS,+
    DOI:——
    日期:——
  • The synthesis of novel GABA uptake inhibitors. Part 2. Synthesis of 5-hydroxytiagabine, a human metabolite of the GABA reuptake inhibitor tiagabine
    作者:Knud E. Andersen、Mikael Begtrup、Mukund S. Chorghade、Elaine C. Lee、Jesper Lau、Behrend F. Lundt、Hans Petersen、Per O. Sørensen、Henning Thøgersen
    DOI:10.1016/s0040-4020(01)85345-x
    日期:1994.1
    (R)-1-(4-(2,5-Dihydro-3-methyl-5-oxothien-2-ylidene)-4-(3-methyl-2-thienyl)butyl)-3- piperidinecarboxylic acid (5-hydroxytiagabine) 13, has been prepared in 8 steps from 2-bromo-3-methylthiophene 3. Key steps are Grignard reactions, displacement of heteroaromatic chlorine with methoxy, and simultaneously demethylation and opening of a hydroxymethylcyclopropane with bromotrimethylsilane. An alternative approach involving acylation of 2-lithio-3-methylthiophene 17a was found less satisfying. A metalloporphyrin assisted hydroxylation of tiagabine 1 also yielded the target metabolite. The structure of 5-hydroxytiagabine was confirmed by NMR-data including COSY, ROESY, HMQC and HMBC experiments.
查看更多